Abstract-Kinetic modeling of myocardial perfusion imaging data allows the absolute quantification of myocardial blood flow (MBF) and can improve the diagnosis and clinical assessment of coronary artery disease (CAD). Positron emission tomography (PET) imaging is considered the reference stan-
I. INTRODUCTION

M
YOCARDIAL ischaemia is an essential prognostic determinant in coronary artery disease (CAD) and noninvasive methods for ischaemia assessment are important for the clinical management of patients with known or suspected CAD [1] . The current noninvasive clinical standard assessment for myocardial ischaemia is based on visual estimates from perfusion imaging data which are limited to identifying regional perfusion changes. The diagnostic performance of visual estimates is particularly compromised in conditions where MBF is diffusely abnormal, such as in multivessel disease, or where microvascular dysfunction may be present [2] . Kinetic modeling of myocardial perfusion imaging data can allow the absolute quantification of myocardial blood flow (MBF), which has the potential to improve the diagnosis of CAD, the assessment of coronary microcirculation and to precisely assess MBF changes following therapeutic interventions [2] , [3] .
Positron emission tomography (PET) imaging benefits from a direct relationship between signal intensity and the radioactivity concentration in the tissue of interest and is considered the reference standard technique for absolute quantification of 2469-7311 c 2018 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
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MBF [4] . In the context of MBF quantification, previous studies demonstrated the applicability of oxygen-15 ( 15 O)-water in PET perfusion imaging [4] , [5] . For a metabolically inert freely diffusible tracer such as 15 O-water, single-tissue compartmental models are commonly used for MBF quantification without the need for radio-metabolite correction in the arterial blood [5] , [6] . However, additional post-processing techniques are required to correct for spill-over effects between the left, right ventricular arterial blood, and myocardial tissue compartments and for the low-signal gradient between myocardial tissue and arterial blood [2] , [4] - [6] . Perfusion analysis software implements different methods for spill-over correction and myocardial tissue delineation [4] , [7] , [8] . Although strong correlations in MBF quantification derived from different available PET perfusion analysis software (Carimas versus Cardiac VUer) have been previously shown [9] , there is no previous work comparing the diagnostic ability of different perfusion analysis softwares to detect hemodynamic differences in the presence of obstructive CAD. Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) using gadolinium-based extracellular contrast agents, has also been used to derive absolute quantification of MBF. Quantitative MR studies have previously shown comparable diagnostic performance for the detection of obstructive CAD [10] - [12] compared to quantitative 15 Owater PET [13] - [15] . Various MR models have been used to describe the kinetics of gadolinium-based contrast agents through the myocardium. Their diagnostic performance in detecting obstructive CAD has been assessed, with Fermi deconvolution modeling showing high diagnostic accuracy and being the most established approach [3] , [10] , [11] . The Fermi model is an empirical-mathematical model used to estimate MBF from MR perfusion data during first-pass of gadolinium-based extracellular contrast agents [10] , [12] . Our group recently demonstrated that distributed parameter (DP) deconvolution modeling showed superior diagnostic performance against Fermi modeling for the detection of obstructive CAD using 3T MR and our results compared favorably against previous MR studies [12] . The DP model is based on tracer kinetics analysis and it can provide MBF quantification and additional information about coronary vascularity and permeability, such as estimates of intravascular space, extravascular-extracellular space, extraction fraction, permeability surface area product, and volume of distribution [12] , [16] , [17] . MR-derived MBF has been assessed against PET-derived MBF quantification in patients with CAD by using ammonia-13 ( 13 N) and rubidium-82 ( 82 Rb), which showed weak [18] and stronger [19] correlations, respectively. Despite these first multimodality MBF comparisons, Fermi-and DP modeling-derived MBF quantification from DCE-MR data have not been assessed against 15 O-water PET data in patients with CAD.
The objectives of this paper were twofold. We evaluated the diagnostic performance of two dedicated software packages, Carimas and PMOD, to detect obstructive CAD against the current clinical standard assessments of invasive coronary angiography and fractional flow reserve in a pilot population. We also assessed for the first-time Fermi-and DP modeling-derived MBF quantification from DCE-MRI against 15 O-water PET data, acquired in patients with CAD.
II. METHODS
A. Study Population
The study was performed with the approval of the institutional research ethics committee and in accordance with the Declaration of Helsinki, as previously described [20] . Following informed consent, 15 O-water PET was acquired in 20 patients with history of stable angina and known or suspected CAD. Results are also presented here for a subset of six subjects who agreed to receive DCE-MRI, prior to standard clinical invasive CAD assessments (maximum interval between PET and MR imaging was seven days). All subjects were instructed to abstain from caffeine for 12 h before PET and MR imaging, which acts as an adenosine receptor antagonist and can otherwise affect adenosine-induced stress imaging [11] , [14] . Exclusion criteria for subject recruitment included history of severely compromised renal function (serum creatinine greater than 2.26 mg/dL or glomerular filtration rate ≤ 30 mL/min), pregnancy and contraindications to adenosine or MR imaging. All patients underwent invasive coronary angiography and fractional flow reserve.
B. Cardiac Positron Emission Tomography
Rest and adenosine stress 15 O-water PET was performed using a hybrid PET-CT scanner (128-multidetector Biograph mCT, Siemens Medical Systems, Germany), as previously described [20] . Attenuation correction computed tomography imaging maps was acquired before rest and stress imaging. 15 O-water was produced by an on-site cyclotron (PETtrace 8, GE Healthcare, U.K.) and a radiowater generator (Hydex Oy, Finland) generated the 15 O-water bolus. For rest imaging, a target of 500 MBq 15 O-water bolus was injected intravenously over 15 s and the venous line was then flushed for another 2 min. The dynamic acquisition was performed over 5 min (14 frames × 5 s, 3 frames × 10 s, 3 frames × 20 s, and 4 frames × 30 s).
Following suitable radioactivity decay (of approximately 10 min), stress imaging was performed with intravenously administering adenosine for 4 min (140 μg/kg/min, Adenoscan, Sanofi Aventis) [13] , [20] . The above protocol was then repeated using a further dose of 500 MBq 15 O-water bolus. Dynamic emission images were reconstructed using the standard UltraHD algorithm (Siemens Medical Systems, Germany) with a zoom of 2.00, matrix 128 × 128, voxels 3.18 × 3.18 × 3 mm.
C. Cardiac Magnetic Resonance Imaging
DCE-MRI imaging was acquired in a 3T Verio imaging system (Siemens, Healthcare Gmbh, Erlangen, Germany) using electrocardiogram-gating, as previously described [12] . Standard cardiac imaging planes and a short axis stack of left ventricular cine data were acquired using routine steady state free precession (TrueFISP) acquisitions. Modified look-locker inversion recovery (MOLLI) T 1 maps were acquired using the Siemens Works in Progress Package #448, Quantitative Cardiac Parameter Mapping [21] .
Stress imaging was performed by implementing the same adenosine infusion protocol as described above for 4 min [10] , [12] . Fifty dynamic perfusion images were obtained at diastole across three short-axis view slices, covering 16 of the standard myocardial segments [22] . For dynamic imaging, a turbo-fast low angle shot (FLASH) saturation recovery prepared single-shot gradient echo pulse sequence was used with imaging parameters: flip angle 12 • , repetition time/echo time 2.20 ms/1.07 ms, slice thickness 8 mm, preparation pulse delay to central line of k-space 100 ms, matrix size 192 × 108 and FoV 330 mm × 440 mm. Parallel imaging was performed with the application of GRAPPA (accelerator factor of 3) and partial Fourier acquisition of 0.75, which led to 48-phase encoding lines for each dynamic frame. An intravenous bolus of 0.05 mmol/kg of a gadolinium-based contrast agent (Gadovist, Bayer Healthcare) followed by 20 mL of 0.9% saline (Medrad Spectris Solaris, Medrad, USA) was injected at 4 mL/s using an MR compatible pump injector (Spectris Solaris, Medrad, Bayer). To allow clearance of residual contrast agent, rest perfusion imaging was performed 15 min after stress imaging, with the same acquisition protocol for all six subjects.
D. Invasive Coronary Angiography and Fractional Flow Reserve
Subjects underwent invasive coronary angiography and fractional flow reserve (clinical reference standard assessments) at the Royal Infirmary of Edinburgh. Invasive coronary angiography was performed via the radial artery as per standard clinical practice [20] , [23] . Fractional flow reserve was assessed for major epicardial vessels and defined as the ratio between distal coronary pressure and aortic pressure measured simultaneously at maximal adenosine-induced (intravenous 140 μg/kg/min) hyperemia [23] . Obstructive CAD was defined as luminal stenosis ≥ 70% on invasive coronary angiography alone, or luminal stenosis ≥ 50% and fractional flow reserve ≤ 0.80 [12] , [20] . (No, minor, or non)-obstructive CAD was defined as luminal stenosis < 50% or luminal stenosis ≥ 50% and fractional flow reserve > 0.80 [12] , [20] .
E. Quantitative 15 O-Water PET Analysis
15 O-water PET data were analyzed with two dedicated softwares (Carimas 2.9, www.turkupetcentre.net, Finland and PMOD 3.7, www.pmod.com, Switzerland), using single-tissue compartment modeling. The single-tissue compartment model can be mathematically described by
where C t (t) and C a (t) are the radioactivity concentrations extracted by the myocardial tissue and the arterial blood from the left ventricular blood pool, respectively, and p is the partition coefficient of 15 O-water (i.e., myocardial to blood radioactivity concentration at equilibrium, when the net tracer flux between the compartments is zero; a constant value of 0.95 mL/mL for Carimas [7] and of 0.96 mL/mL for PMOD modeling [24] were used). Myocardial contours were defined in short axis views, automatically with manual adjustment on digital subtraction images in Carimas [7] , and semi-automatically with manual adjustment on images generated by factor analysis in PMOD [24] . In Carimas, digital subtraction images were automatically generated. For factor analysis in PMOD, volumes of interest were initially outlined within the left and right lungs, from which an average lung time activity curve was extracted. By time-shifting this lung time activity curve (automated time shift of −5 and 5 s for the right and left ventricle, respectively), approximations of two synthetic time activity curves in the right and left ventricle were derived. A third synthetic time activity curve corresponding to myocardial uptake was then calculated by solving the single-tissue compartment model with the shifted lung time activity curve (8 s) and by using a mean MBF value of 1 mL/min/mL [24] . All synthetic time activity curves were then used to automatically estimate weighted factors for the myocardium and leftventricular blood pool for each dynamic frame, as described by Hermansen et al. [25] and factor analysis images were generated.
Carimas and PMOD performed correction for spill-over fractions from the left [7] and left and right ventricles [24] , respectively. In Carimas post-processing, the measured radioactivity concentration derived from the images was expressed as a function of true radioactivity (radioactivity without the spill-over fractions) in the myocardium and left ventricular blood pool, as described in the following system of equations:
where TF, C tt , V a , C ta , and β are the perfusable tissue fraction and true radioactivity in the myocardial tissue, the arterial vascular space (including the spill-over from the left ventricle blood pool), the true radioactivity in the left ventricular blood pool and the recovery coefficient (i.e., the ratio of measured to known radioactivity, a constant value of 0.93 was used), respectively. MBF quantification in Carimas was then performed in a 2-step process. Following substitutions in (1) and (2), and integration, the first operational equation was derived, which is a function of measured radioactivities in the left ventricular blood pool and myocardial tissue and fitted in a time activity curve extracted from the whole (nonsegmented) myocardium, using multilinear regression analysis for model fitting (see Table I ) [26] . This first step allowed the calculation of the true radioactivity concentration in the left ventricular blood pool C ta . By solving for C tt (t) in the former expression of the system equation (2), integrating and substituting into equation (1), the final operational equation (second step) was then derived which was expressed as a function of true radioactivity C ta (t) (measured from step 1) in the left ventricular blood pool (Table I) . From the fitted parameters K 1 , k 2 , and V fit of this operational equation MBF, TF, and V a were calculated and MBF parametric maps (per pixel analysis) were generated. Mathematical derivations for true tissue radioactivity C tt , true radioactivity in the left ventricular blood pool C ta as well as for MBF, TF, and V a calculations and explicit mathematical processing in Carimas, are further described in the Turku PET Centre Modeling report website link (www.turkupetcentre.net/reports/tpcmod0005.pdf). In PMOD, by numerically integrating equation (1) and incorporating the spill-over corrections, the operational equation was derived (Table I ) and fitted to the time activity curves extracted from myocardial tissue regions of interest using iterative nonlinear least square fitting (1-step process) [24] . In PMOD, the operational equation was expressed in terms of the fitted parameters TF, V LV , V RV , and C aRV : perfusable tissue fraction in the myocardial tissue, spill-over fraction from the left ventricle, spill-over fraction from the right ventricle, and radioactivity concentration in the right ventricle blood pool, respectively. Spill-over correction from the right ventricle (V RV ) was fitted for septal myocardial segments and was set to zero for nonseptal myocardial areas. Details about PMOD post-processing are further described in the PMOD website link (doc.pmod.com/PDF/PKIN.pdf). A list of notations for all kinetic modeling parameters are summarized in the supplementary material 1.
F. Quantitative DCE-MRI Analysis
Endocardial and epicardial MR contours were manually outlined using validated cardiac image analysis software (QMass, Medis, The Netherlands). Myocardial and arterial input function signal intensity-time curves were converted to gadolinium concentration-time curves using the method of Larsson et al. [27] as previously described [10] , [12] , [28] . According to this, the longitudinal relaxation rate R 1 (1/T 1 ) changes linearly as a function of contrast agent concentration influx C(t) in the tissue at time t, multiplied by its relaxivity r 1 :
where
is the native longitudinal relaxation rate and T 1 (t) is the longitudinal relaxation rate at time t of contrast enhancement. R 1 (t) can be calculated by adapting the MR signal equation for the saturation recovery prepared single-shot FLASH sequence [10] , [28] 
where S(t) is the equilibrium signal intensity at time t, is a calibration constant dependent on instrument conditions, such as the receiver gain, the proton density, and the flip angle α. PD is the prepulse delay which is the time between saturation pulse and the central line of k-space, n is the number of applied pulses of flip angle α. can initially be calculated from (4) using native T 1 (0) (measured with MOLLI [21] ). R 1 (t) at time t of contrast enhancement can then be calculated from (4), using and S(t) values extracted from the same region of interest. Contrast agent concentration-time curves can then be calculated using (3) .
Model-dependent deconvolution analysis was implemented to measure MBF using Fermi and 1-barrier 2-region DP functions as previously described [12] . Fermi parameterization is an empirical 3-parameter model fit in which τ o defines the width of the initial plateau of the tissue impulse response before it decays mono-exponentially at a rate given by the parameter k (see fitted parameters of Fermi function in Table I ) [29] . The Fermi model is fitted to the first-pass phase of contrast enhancement. This is estimated by setting the end-point at the contrast agent concentration minimum in the arterial input function, before the recirculation component begins (this range varies from patient to patient and is commonly in the range between 20 and 35 dynamic frames) [12] . DP parameterization is a 4-parameter model fit based on tracer kinetics analysis and its tissue impulse response is expressed in terms of the fitted parameters T, T c , and T e : T is mean overall transit time, T c is mean capillary transit time, and T e is mean interstitial (i.e., extravascular-extracellular) transit time (Table I) . DP modeling describes the intravascular space as a plug flow system, whilst assumes no axial indicator transport in the extravascular-extracellular space [16] , [17] . The third and fourth fitted parameter for Fermi and DP deconvolution analysis, respectively, was MBF. DP model fitting was performed in the Laplace domain to avoid the discontinuities of the time step-function that can be present when fitting the DP model in the time domain [30] . To account for the time delay (between the onset of contrast enhancement in the blood pool and the myocardium), both models were fitted to the data multiple times from zero to six times the temporal resolution starting from the onset of contrast enhancement in the blood pool and the time delay reaching the optimal x 2 fit to the data was used in the analysis.
A standardized American Heart Association (AHA) 16-segment model of the heart was generated across all modeling applications [22] . In Carimas, the per pixel analysis was averaged for each of the 16-myocardial segments. For both 15 O-water PET and DCE-MR analysis, myocardial perfusion reserve (MPR) was also calculated by dividing the hyperemic by the resting MBF. MBF and MPR were quantified for each of the 16 myocardial segments and were then averaged per epicardial vessel territory (vessel territories corresponded to the three main coronary vessels, defined according to the 16 segment model [22] ). Mean values for MBF at stress and MPR were classified accordingly in two groups for per vessel and per patient based analysis (see classification in the results section).
G. Statistical Analysis
Blinded and independent analysis of 15 O-water PET and DCE-MRI data was performed using dedicated statistics software (R Foundation for statistical computing, Vienna, Austria; MedCalc Software, Ostend, Belgium). Linear regression and Pearson's correlation coefficients were used to investigate correlations in MBF estimates between different modeling applications, for both 15 O-water PET and DCE-MRI, in a per segment and per vessel basis. Bland Altman analysis was implemented to investigate systematic bias between all modeling applications. Hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD and between all modeling applications in a per segment basis, were investigated by implementing two sample t-test (twosided P value < 0.05 were considered significant). For the Carimas versus PMOD comparison, receiver-operating characteristic (ROC) analysis was used on a per vessel and per patient basis to determine threshold values for absolute MBF at stress and MPR with the greatest sensitivity and specificity to detect obstructive versus (no, minor, or non)-obstructive CAD (group 2 versus group 1, see results). The area under the curve (AUC) was calculated using trapezoidal numerical integration and a DeLong et al. [31] nonparametric comparison was performed to compare the diagnostic performance of 15 Owater PET quantitative methods. The maximal Youden Index was used to determine the optimal threshold values [10] , [12] .
III. RESULTS
The baseline characteristics of the full patient cohort are presented in Table II . Quantitative 15 O-water PET analysis was performed in 20 patients, in which the diagnostic performance of Carimas versus PMOD in detecting obstructive CAD was investigated. For six of these patients, quantitative DCE-MRI analysis was also performed and correlations and agreements in MBF measurements were investigated against 15 O-water PET (Fig. 1) .
For each subject, MBF quantification across all four modeling methods was performed for each of the 16 myocardial segments, in per segment analysis. Myocardial segments with (no, minor, or non)-obstructive and obstructive CAD were then classified based on the invasive coronary angiography and fractional flow reserve data, in groups 1 and 2, respectively. In per vessel analysis, segmental MBF values were averaged per epicardial vessel territory (three main coronary vessels, as per the 16-segment AHA model) [10] , [15] , [22] . Vessel territories with (no, minor, or non)-obstructive CAD were classified in group 1 and vessels with obstructive CAD were classified in group 2. For per patient analysis, patients with all vessel territories detected with (no, minor, or non)-obstructive CAD were classified in group 1, whilst patients with at least one vessel identified with obstructive CAD, were classified in group 2 [12] .
A. Carimas Versus PMOD Analysis
Quantitative 15 O-water PET analysis was performed in 60 vessel territories in total (20 patients, 3 vessel territories each). Seven patients had at least one vessel identified with obstructive CAD: 3 patients had 1-vessel disease, 3 had 2-vessel disease, and 1 had 3-vessel disease. Examples of model fitting and arterial input functions from both modeling approaches are presented in Fig. 2 .
On linear regression and Pearson's correlation, PMOD and Carimas-derived MBF showed strong, significant correlations (P < 0.001), in both per segment (r = 0.88) and per vessel (r = 0.91) analysis. Carimas overestimated PMOD MBF estimates at stress (P < 0.05), whilst underestimated PMOD MBF estimates at rest (P < 0.01).
On Bland Altman analysis, the average bias was calculated as the Carimas-derived estimates minus the PMOD modelingderived estimates. The systematic bias was low in both per segment and per vessel basis: 0.16 (−1.18, 1.50) versus 0.16 (−0.95, 1.28), respectively.
Hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD were initially assessed in a per segment basis. Significant differences in stress MBF values between myocardial segments classified in group 1 versus group 2 were higher (4 orders of magnitude) for PMOD modeling against Carimas modeling, respectively (P < 0.0001).
ROC analysis curves were subsequently investigated in per vessel and per patient analysis, shown in Fig. 3 . Mean (SD) values for Carimas and PMOD-derived MBF and MPR in groups 1 and 2 for per vessel analysis are shown in Table III . All hemodynamic thresholds estimated on ROC analysis are presented in Table IV . In per vessel ROC analysis, the AUCs for PMOD were significantly higher compared to Carimas modeling, for both MBF at stress and MPR (Table IV) . The diagnostic performance of PMOD consistently outperformed Carimas modeling (Table IV) .
Mean (SD) values for Carimas and PMOD-derived MBF and MPR in groups 1 and 2 for per patient analysis are presented in Table III . In per patient ROC analysis, the AUCs for PMOD were significantly higher whilst the diagnostic performance was consistently superior for PMOD modeling compared to Carimas modeling, for both MBF at stress and MPR (Table IV) .
B. DCE-MRI Versus 15 O-Water PET
Quantitative 15 O-water PET against DCE-MRI analysis was performed in 18 vessel territories in total (six patients, three vessel territories each). Mean values (SD) and significant differences for all modeling applications, for groups 1 and 2, are shown in Fig. 4 . Significant differences between groups 1 and 2 were equivalent (P values in the same order of magnitude) for DP against PMOD modeling (Fig. 4 , P < 0.0001). Significant differences were higher (two orders of magnitude) for DP and PMOD modeling against Carimas and Fermi modeling, respectively (Fig. 4, P < 0.0001 ). An example file presenting per segment analysis across all models for a patient with obstructive CAD is shown in the supplementary material 2. 
TABLE III MEAN (SD) VALUES IN PER VESSEL AND PER PATIENT CLASSIFICATION FOR CARIMAS (CAR) AND PMOD MODELING
There were no significant differences between DP, Carimas, and PMOD modeling-derived MBF values at stress. Fermi modeling significantly overestimated MBF compared with all other modeling applications, both at stress and rest (P < 0.01). DP and Fermi modeling-derived values overestimated Carimas and PMOD modeling-derived values at rest (P < 0.001).
On linear regression and Pearson's correlation analysis, MBF estimates derived from 15 O-water PET and DCE-MRI data, were initially separately assessed. Carimas versus PMOD MBF values, as well as DP versus Fermi MBF values, showed significant correlations in per segment and per vessel analysis (Table V, P < 0.001).
On Bland Altman analysis, the average bias was calculated as the Carimas-derived estimates minus the PMOD modeling-derived estimates for 15 O-water PET data; and Fermi modeling-derived estimates minus the DP modeling-derived estimates for DCE-MRI data (Table V) . The systematic bias was low, mainly for 15 O-water PET data, which was eliminated in per vessel analysis.
Subsequently, MBF measurements from DP and Fermi modeling from DCE-MRI data were compared against measurements from Carimas and PMOD modeling from 15 O-water PET data. Similarly, there were significant (P < 0.001) correlations for all comparisons, whilst DP and Fermi modeling showed consistently better correlations with PMOD modeling (Fig. 5) , compared to Carimas analysis (Table V) .
On Bland Altman analysis, the average bias was calculated as PMOD-and Carimas modeling-derived estimates minus DP modeling-derived estimates; and the Fermi modeling-derived estimates minus the PMOD-and Carimas-modeling-derived estimates (Table V) . The lowest systematic bias was observed between PMOD and DP-modeling derived MBF, although with broader limits of agreement, compared to Fermi modeling (Table V, Fig. 5 ). 
IV. DISCUSSION
The main outcomes of this paper demonstrated that PMOD showed higher hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD in per segmentbased analysis, as well as consistently outperforming Carimas modeling in both per vessel and per patient analysis. Beyond strong, significant correlations across all MR versus PET comparisons, DP and PMOD analysis showed comparable and higher hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD, against Fermi and Carimas analysis.
A. Carimas Versus PMOD
To date, this is the first study assessing diagnostic performance for the detection of obstructive CAD, using Fig. 4 . Mean MBF (SD) and significant differences between groups 1 (nonobstructive CAD) and 2 (obstructive CAD), for all modeling applications. All models showed significant differences between groups 1 and 2 (P < 0.0001). Significant differences were higher for PMOD and DP modeling, compared to CAR and Fermi modeling ( † show two orders of magnitude smaller P values compared to *).
more than one perfusion analysis software. Our correlation coefficients for Carimas versus PMOD estimates are in agreement with similar comparisons performed in 15 O-water PET [4] and in 82 Rb-rubidium PET [32] , which showed good correlations between different cardiac PET perfusion quantification software. Despite the larger patient cohorts previously analyzed, none of these studies compared the diagnostic ability of the different software examined in detecting reduced blood flow in the presence of obstructive CAD. In our pilot cohort, we assessed hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD in per segment analysis, as well as performed full diagnostic performance in per vessel and per patient level on ROC analysis. We demonstrated that PMOD consistently showed higher hemodynamic differences and superior diagnostic performance in detecting obstructive CAD, compared with Carimas. These results indicate that it may be important to fully assess hemodynamic differences and diagnostic performance, beyond just MBF cross-correlations, when different perfusion softwares are compared.
The diagnostic performance for PMOD was in agreement with a previous 15 O-water PET study [14] , whilst compared favorably against other findings on a per vessel [33] , or per patient basis [8] . The highest diagnostic performance for the detection of obstructive CAD was reached by PMOD-derived MBF at stress in per vessel analysis, which is consistent with a previous 15 O-water study where the PMOD-derived sensitivity and specificity were higher in per vessel compared to per patient-based analysis [33] . Moreover, the diagnostic performance of MBF at stress was consistently higher compared to MPR for both Carimas and PMOD, as previously demonstrated [8] , [15] , [33] . In this paper, a small pilot cohort was investigated with a low number of patients with obstructive and multivessel CAD. Microvascular dysfunction that may be present in patients with minor or nonobstructive CAD (see risk factors in Table II : rates for hypertension, hypercholesterolemia, ex-smokers, and revascularization [12] , [14] ), can also lead to MBF reductions, which in turn can compromise the specificity for the detection of obstructive CAD-specific MBF reductions [12] . We showed that Carimas overestimated PMOD estimates at stress hence, any MBF overestimations in myocardial segments classified with obstructive CAD could explain its lower sensitivity versus PMOD, in our data. These factors together with differences in patient cohorts and acquisition protocols can explain the lower diagnostic performance detected for the case of Carimas modeling, in comparison with a previous study which used the same software in a larger patient cohort (38 out of 104 patients scanned had obstructive CAD) and higher 15 O-water doses (maximum of 1100 MBq for each 15 O-water injection) [13] .
Our hemodynamic thresholds on ROC analysis for PMOD and Carimas-derived MBF (Table V) were consistent with previous 15 O-water PET studies which identified thresholds in the range between 1.85 and 2.50 mL/min/mL, for both per vessel and per patient-based analyses [8] , [13] , [14] , [33] , [34] . Furthermore, these thresholds agree with Fermi (2.49, 2.60 mL/min/mL) and DP (1.75, 2.00 mL/min/mL) modelingderived thresholds in per vessel and per patient analysis, respectively, estimated by our group [12] . Differences in 15 O-water doses, PET protocols and scanners, image reconstruction, post-processing techniques, and angiographic thresholds defining obstructive CAD can explain any hemodynamic threshold variations between 15 O-water PET studies, including the current work [13] , [33] . We also demonstrated that Carimas overestimated and underestimated PMOD estimates at stress and rest, respectively, which can explain the higher threshold values identified for Carimas-derived MPRs, in both per vessel and per patient analysis.
Technical disparities between Carimas and PMOD can interpret the diagnostic performance differences demonstrated. Although no spill-over correction from the right ventricle in Carimas means that it would mainly affect MBF measurements in septal myocardial segments (anatomically located between the left and right ventricle), it also overestimated PMOD MBF values at stress in nonseptal areas. A considerable disparity between Carimas and PMOD post-processing, is the pixel by pixel-based (using a linear least square approach described in [26] ) versus segment-based (using standard nonlinear least square fitting) method for model fitting, respectively. Differences between linear versus nonlinear least square approaches have been assessed using singletissue compartmental modeling and demonstrated that linear least square methods may compromise the accuracy of MBF quantification [26] , [35] . In contrast, other studies showed that the linear least square and/or generalized linear least square (designed to reduce estimation bias of the linear least square method) approaches can provide accurate estimates of blood flow, compared to the standard nonlinear least square (segment-based) method [36] - [38] . Boellaard et al. [39] compared different methods for pixel-based MBF analysis and demonstrated that the basis function method was independent of the noise level and provided the most accurate perfusion estimates, compared to the linear least square and generalized linear least square approaches. Further work is needed to elucidate to what degree the linear least square approach used has affected the diagnostic performance of the Carimas software. Another important difference in the post-processing between Carimas and PMOD is the 2-step versus 1-step mathematical modeling, respectively. This involves fitting different operational equations for the two softwares and thus, MBF estimations differ: MBF is indirectly estimated through the fitted parameter K 1 ' in Carimas (described in methods, Table I , and Carimas documentation), whilst directly calculated from the fitted parameter MBF in PMOD. These disparities can suggest that any Carimas-derived MBF overestimations may be due to a combination of the above technical differences, beyond just methodological differences in the spill-over correction approach.
B. DCE-MR Versus 15 O-Water PET
We demonstrated for the first time strong correlations between DP/Fermi modeling-(from DCE-MRI) versus Carimas/PMOD modeling-derived values (from 15 O-water PET) in a subgroup of patients with CAD. This is also the first study comparing DP modeling against PET. In per segmentbased analysis, we showed that hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD were comparable for DP and PMOD, against Fermi and Carimas analysis. Due to the small number of subjects in this subgroup of patients, it was not possible to perform a full diagnostic performance comparison (ROC analysis) for obstructive CAD detection across all our MR versus PET comparisons. However, our PET findings are consistent with the higher hemodynamic differences presented in our full cohort for PMOD in per segment level, for which superior diagnostic performances were consistently demonstrated against Carimas. Similarly, our MR findings are also consistent with the higher hemodynamic differences showed in our previous study for DP modeling in per segment level [12] , for which higher diagnostic performances were consistently shown, against Fermi modeling.
Direct comparisons in correlation coefficients against previous MR versus PET studies are difficult because of variations in the image acquisition and analysis techniques [18] , [19] , [40] - [42] . However, our correlation coefficients compare favorably against previous studies comparing two-compartmental and Fermi MR-derived MBF against PET [19] , [40] respectively, whilst are in agreement with other studies that assessed model-independent, modelindependent/Fermi, and single-tissue compartment/Patlak MR derived MBF against PET [18] , [41] , [42] , respectively. Two studies have previously compared DCE-MRI against 15 O-water PET data in healthy subjects [40] , [42] . Pärkkä et al. [40] used 18 healthy volunteers and showed weaker perfusion correlations compared to our data analysis. Despite the larger healthy volunteer cohort used in this paper, it was not possible to investigate correlations across different hemodynamic states (MBF at stress in no, minor, non-obstructive, obstructive CAD, MBF at rest), assessed in our pilot cohort. Also for the MR analysis, the parameter K trans was estimated from which a direct estimate of MBF is not possible, as its physiological interpretation reflects a mixture of blood flow and the permeability surface area product [17] . Our correlation coefficients agree with the study by Tomiyama et al. [42] , which showed strong correlations between single-tissue compartment model (per vessel analysis across 10 subjects, r = 0.92) and Patlak model (per vessel analysis across ten subjects, r = 0.80) derived MBF against an in-house software for 15 O-water PET data analysis.
Although PET imaging is considered the reference standard for MBF quantification and therefore it is important for validating MR perfusion, each tracer has its own limitations [2] , [5] , [6] . The main limitations for the analysis of 15 O-water are the need to correct for the high 15 O-water activity in the blood pool and for the spill-over from the left and right ventricles [2] , [5] . Our multimodal comparisons against invasive methods showed that PMOD may be able to effectively minimize the impact of the above limitations for MBF quantification compared to Carimas, and that it may be a useful analysis tool for validating quantitative MR perfusion. DP modeling did not show significant differences against Carimas and PMOD estimates for MBF at stress, but significantly overestimated MBF at rest [see Fig. 5(b) ]. Fermi modeling showed strong correlations against PMOD and Carimas, but it significantly overestimated MBF values, compared to all other modeling applications [ Table V , Fig. 5(d) ]. These MR-derived MBF overestimations are in agreement with previous studies demonstrating rest [19] and stress-rest overestimations [41] compared with PET estimates. Further work needs to be done to assess which methodological disparities may cause consistent differences in MBF quantification between MR and PET [18] , [19] , [40] - [43] and to what degree these can affect the diagnostic performance of quantitative MR and PET protocols.
C. Study Limitations
Our diagnostic performance comparison between Carimas and PMOD was performed in a small pilot cohort. However, this is the first study comparing the diagnostic ability of different PET perfusion analysis software for detecting reduced MBF in obstructive CAD, which showed considerable differences between the two techniques. Any changes in the acquisition protocol, the 15 O-water dose or the reconstruction technique would necessitate a diagnostic performance reassessment for both MBF quantification techniques [2] , [6] . Our MR versus PET analysis was assessed in a small subgroup of patients. For DCE-MRI, we used a single bolus protocol that may be prone to arterial input function saturation effects at the peak of contrast enhancement, which can lead to MBF overestimations [10] , [28] . Arterial input function saturation could be more pronounced in our 3T data, compared to perfusion data from 1.5T. Our group previously demonstrated that DP modeling is less dependent on arterial input function saturation compared to Fermi modeling (at 3T) [12] . Fermi modeling may derive smaller systematic bias against PET compared to our findings, if either dual bolus protocols [28] and/or 1.5T [10] would be used for minimizing signal saturation. Despite any Fermi-derived overestimations due to arterial input function saturation effects, our findings are consistent with other studies which showed that Fermi estimates were systematically increased compared to DP modeling (at 3T) [12] , to model-independent, two-compartmental and Patlak model analysis (mixture of 1.5 and 3T were used) [44] as well as to uptake model and model-independent analysis (at 1.5T) [10] .
V. CONCLUSION
In conclusion, we demonstrated consistently superior diagnostic performance for the detection of obstructive CAD when PMOD was used versus Carimas in 15 O-water PET data. Although we showed strong, significant cross-correlations between MR against PET quantitative perfusion analysis, PMOD and DP analysis detected comparable and higher hemodynamic differences between obstructive versus (no, minor, or non)-obstructive CAD, compared to Carimas and Fermi analysis.
Our MR method assessments against the optimum PET reference standard technique for perfusion analysis showed promising results in per segment level and can support further multimodality assessments in larger patient cohorts. Further MR versus PET assessments may help to determine the comparative diagnostic performance of both quantitative methodologies for obstructive CAD detection.
